December 12, 2017
Lilly strengthens its oncology department with a new name
Eli Lilly said on Monday that Kimberly Blackwell, M.D., one of the USA’s leading breast cancer researchers, will join Lilly Oncology as…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
December 12, 2017
FDA will review Eli Lilly’s Galcanezumab for the prevention of migraine in adults
Eli Lilly said on Monday that the U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) to review…
December 12, 2017
Juno, Calgene announce more potential of CAR T therapy
Juno Therapeutics, a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, and Celgene Corporation have additional data from the…
December 11, 2017
prophylactic dosing with Alprolix provides safe and effective protection in people with severe haemophilia B
SOBI and Bioverativ on Monday announced the results of a new post-hoc longitudinal analysis demonstrating that individualised dosing with extended…
December 7, 2017
Tresiba reduces hypoglycaemia regardless of blood sugar level
People with either type 1 or type 2 diabetes treated with Tresiba had fewer episodes of low blood sugar (hypoglycaemia) compared…
December 6, 2017
ProcureCon Pharma 2018: event for senior pharma procurement professionals
We are very proud to be partnering with the ProcureCon Pharma 2018, the only event in Europe for senior pharma…
December 6, 2017
GSK’s Shingrix able to prevent shingles in autologous haematopoietic stem cell transplant patients
GlaxoSmithKline said on Wednesday that new data from a Phase III clinical study supports the safety and efficacy of Shingrix…
December 6, 2017
ADC Bio signs construction agreement with sector specialists WHP
ADC Biotechnology (ADC Bio) – a specialist ADC contract services company with proprietary conjugation technology designed to overcome process and aggregation…
December 5, 2017
Plasticell and Anthony Nolan to partner in clinical trials of ex vivo expanded cord blood stem cells
Plasticell, a developer of innovative stem cell technologies and cell therapies, today announced it will collaborate with Anthony Nolan, a…
December 5, 2017
Mylan and Aspen to launch generic Busulfex injection
Mylan and its partner, Aspen have announced the U.S. launch of Myleran (busulfan) Injection, 60 mg/10 mL (6 mg/mL) Single-dose…